CardioDx Launches Gene Test For Obstructive Coronary Disease
This article was originally published in The Gray Sheet
Executive Summary
CardioDx is gradually rolling out its Corus CAD gene expression test, which quantifies the likelihood of obstructive coronary artery disease in patients with stable chest pain and no previous history of cardiac disease